Chemokines direct endothelial progenitors into tumor neovessels

被引:192
作者
Spring, H
Schüler, T
Arnold, B
Hämmerling, GJ
Ganss, R
机构
[1] German Canc Res Ctr, Dept Mol Immunol, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Biomed Struct Anal Grp, D-69120 Heidelberg, Germany
关键词
cancer; neovascularization;
D O I
10.1073/pnas.0507158102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumor neovasculature substantially derives from sprouting of existing vessels, whereas the functional contribution of bone marrow-derived progenitors to neovessels remains controversial. We used transgenic mouse models of multistep carcinogenesis to monitor incorporation of bone marrow-derived cells into the neovasculature and to elucidate mechanisms of endothelial precursor cell (EPC) recruitment into the tumor microenvironment. We unequivocally demonstrate integration of bone marrow cells into the tumor vasculature as a late event in carcinogenesis that temporally correlates with VEGF release by the tumor and mobilization of circulating EPC in the periphery. Moreover, we demonstrate a chemokine-dependent mechanism of EPC homing into tumor, whereby neovessels of late-stage tumors release a battery of CC chemokines, which direct CCR2(+) and CCR5(+) progenitors into the vasculature. Thus, we show that tumor vessels promote their own growth and development in a self-amplifying fashion.
引用
收藏
页码:18111 / 18116
页数:6
相关论文
共 32 条
[1]   Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells [J].
Aicher, A ;
Heeschen, C ;
Mildner-Rihm, C ;
Urbich, C ;
Ihling, C ;
Technau-Ihling, K ;
Zeiher, AM ;
Dimmeler, S .
NATURE MEDICINE, 2003, 9 (11) :1370-1376
[2]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[3]   Characterization of binding sites for chemokines MCP-1 and MIP-1α on human brain microvessels [J].
Andjelkovic, AV ;
Pachter, JS .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (05) :1898-1906
[4]   VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells [J].
Asahara, T ;
Takahashi, T ;
Masuda, H ;
Kalka, C ;
Chen, DH ;
Iwaguro, H ;
Inai, Y ;
Silver, M ;
Isner, JM .
EMBO JOURNAL, 1999, 18 (14) :3964-3972
[5]   Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization [J].
Berger, M ;
Bergers, G ;
Arnold, B ;
Hämmerling, GJ ;
Ganss, R .
BLOOD, 2005, 105 (03) :1094-1101
[6]   Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells [J].
Chavakis, E ;
Aicher, A ;
Heeschen, C ;
Sasaki, KI ;
Kaiser, R ;
El Makhfi, N ;
Urbich, C ;
Peters, T ;
Scharffetter-Kochanek, K ;
Zeiher, AM ;
Chavakis, T ;
Dimmeler, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (01) :63-72
[7]   Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line [J].
Constien, R ;
Forde, A ;
Liliensiek, B ;
Gröne, HJ ;
Nawroth, P ;
Hämmerling, G ;
Arnold, B .
GENESIS, 2001, 30 (01) :36-44
[8]   Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells [J].
De Palma, M ;
Venneri, MA ;
Roca, C ;
Naldini, L .
NATURE MEDICINE, 2003, 9 (06) :789-795
[9]   HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway [J].
Dimmeler, S ;
Aicher, A ;
Vasa, M ;
Mildner-Rihm, C ;
Adler, K ;
Tiemann, M ;
Rütten, H ;
Fichtlscherer, S ;
Martin, H ;
Zeiher, AM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :391-397
[10]   Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts [J].
Direkze, NC ;
Hodivala-Dilke, K ;
Jeffery, R ;
Hunt, T ;
Poulsom, R ;
Oukrif, D ;
Alison, MR ;
Wright, NA .
CANCER RESEARCH, 2004, 64 (23) :8492-8495